NEW YORK CITY, NY / ACCESS Newswire / September 10, 2025 / WHY: New York, N.Y., September 10, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE:BHVN) between March 24, 2023 and May 14, 2025, both dates inclusive (the "Class Period"), of the important September 12, […]

NEW YORK, NY / ACCESS Newswire / September 10, 2025 / If you suffered a loss on your Alto Neuroscience, Inc. (NYSE:ANRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/alto-neuroscience-inc-lawsuit-submission-form?prid=166456&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Bethany, Okla., Sept. 10, 2025 (GLOBE NEWSWIRE) — In their newly released book, A Legacy of Hope, longtime leaders and brother-sister duo Carol and Albert Gray chronicle the extraordinary transformation of Bethany Children's Health Center – from its beginnings as a small orphanage in 1898 to its place today as one of the nation's premier

New Book, A Legacy of Hope, Traces Four Decades of Faith and Vision Behind Leading Pediatric Health Center Carol and Albert Gray recount how perseverance, miracles, and a steadfast mission transformed Bethany Children's from near closure to one of the nation's premier pediatric hospitals GlobeNewswire September 10, 2025 Bethany, Okla., Sept. 10, 2025 (GLOBE NEWSWIRE)

(NASDAQ:REPL), NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL GlobeNewswire September 10, 2025 NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc. (“Replimune” or the

NEW YORK, NY / ACCESS Newswire / September 10, 2025 / Kirby McInerney LLP reminds Replimune Group, Inc. ("Replimune" or the "Company") (NASDAQ:REPL) investors of the September 22, 2025 deadline to seek the role of lead plaintiff in a pending federal securities class action. If you purchased or otherwise acquired Replimune securities, have information, or

(NASDAQ:LINE), NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Lineage, Inc. (“Lineage” or the “Company”) (NASDAQ: LINE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Lineage and certain of its officers and/or directors have engaged

(NYSE:LMT), NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Lockheed Martin Corporation (“Lockheed” or the “Company”) (NYSE: LMT).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to

(NYSE:FI), NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Fiserv, Inc. (“Fiserv” or the “Company”)(NYSE: FI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their